Eagle Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$57M Buy
624,759
+353,723
+131% +$26.6M 0.29% 111
2024
Q2
$18.4M Sell
271,036
-81,306
-23% -$5.64M 0.1% 195
2024
Q1
$24.1M Sell
352,342
-83,376
-19% -$5.73M 0.12% 166
2023
Q4
$31.2M Buy
435,718
+22,628
+5% +$1.3M 0.17% 146
2023
Q3
$21.5M Buy
413,090
+14,290
+4% +$833K 0.13% 171
2023
Q2
$25.3M Buy
398,800
+172,147
+76% +$10.7M 0.14% 159
2023
Q1
$12.3M Sell
226,653
-40,183
-15% -$1.94M 0.07% 218
2022
Q4
$13.8M Buy
266,836
+11,879
+5% +$595K 0.08% 200
2022
Q3
$11.9M Sell
254,957
-6,500
-2% -$340K 0.08% 214
2022
Q2
$14.9M Buy
+261,457
New +$14.8M 0.09% 201

Other funds holding ITCI